Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003122182 | SCV003790867 | pathogenic | Leukocyte adhesion deficiency 1 | 2022-05-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ITGB2 protein in which other variant(s) (p.Arg593Cys) have been determined to be pathogenic (PMID: 1968911, 7705401, 11703376, 12488604, 25703682). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. A similar copy number variant has been observed in individual(s) with leukocyte adhesion deficiency type 1 (PMID: 17875809). This variant is a gross deletion of the genomic region encompassing exon(s) 12-13 of the ITGB2 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. |